Welcome to LookChem.com Sign In|Join Free

CAS

  • or

124499-37-2

Post Buying Request

124499-37-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

124499-37-2 Usage

General Description

1,4-Dioxaspiro[4.5]decane-8-acetonitrile is a chemical compound with a complex molecular structure. It contains a six-membered cyclic ether (1,4-dioxaspiro), a 10-membered spirocyclic system, and an acetonitrile functional group. 1,4-Dioxaspiro[4.5]decane-8-acetonitrile is used in various chemical reactions and organic synthesis processes. It has potential applications in the pharmaceutical and agrochemical industries due to its unique structural features and reactivity. Additionally, derivatives of 1,4-Dioxaspiro[4.5]decane-8-acetonitrile have been studied for their potential biological activities, making it an interesting target for further research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 124499-37-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,4,9 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 124499-37:
(8*1)+(7*2)+(6*4)+(5*4)+(4*9)+(3*9)+(2*3)+(1*7)=142
142 % 10 = 2
So 124499-37-2 is a valid CAS Registry Number.

124499-37-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(1,4-dioxaspiro[4.5]decan-8-yl)acetonitrile

1.2 Other means of identification

Product number -
Other names 4-cyanomethyl-1,1-ethylenedioxycyclohexane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:124499-37-2 SDS

124499-37-2Relevant articles and documents

Beyond Chemoselectivity: Catalytic Site-Selective Aldolization of Diketones and Exploitation for Enantioselective Alzheimer's Drug Candidate Synthesis

Nugent, Thomas C.,Najafian, Foad Tehrani,Hussein, Hussein Ali El Damrany,Hussain, Ishtiaq

supporting information, p. 14342 - 14348 (2016/09/23)

Site selectivity, differentiating instances of the same functional group type on one substrate, represents a forward-looking theme within chemistry: reduced dependence on protection/deprotection protocols for increased overall yield and step-efficiency. Despite these potential benefits and the expanded tactical advantages afforded to synthetic design, site selectivity remains elusive and especially so for ketone-based substrates. Herein, site-selective intermolecular mono-aldolization has been demonstrated for an array of prochiral 4-keto-substituted cyclohexanones with concomitant regio-, diastereo-, and enantiocontrol. Importantly, the aldol products allow rapid access to molecularly complex ketolactones or keto-1,3-diols, respectively containing three and four stereogenic centers. The reaction conditions are of immediate practical value and general enough to be applicable to other reaction types. These findings are applied in the first enantioselective, formal, synthesis of a leading Alzheimer's research drug, a γ-secretase modulator (GSM), in the highest known yield.

Sulphonamide derivatives

-

, (2008/06/13)

The present invention provides novel sulphonamide derivatives which are useful for potentiating glutamate receptor function in a mammal requiring treatment, processes for their preparation, and pharmaceutical compositions containing them.

Substituted Benzamides with Conformationally Restricted Side Chains. 5. Azabicyclo Derivatives as 5-HT4 Receptor Agonists and Gastric Motility Stimulants

King, Frank D.,Hadley, Michael S.,Joiner, Karen T.,Martin, Roger T.,Sanger, Gareth J.,et al.

, p. 683 - 689 (2007/10/02)

The syntheses of benzamides containing azabicyclo side chains and their 5-HT4 receptor agonist and 5-HT3 receptor antagonist properties are described.These compounds were designed to mimic higher energy conformations of quinol

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 124499-37-2